Independent origins of loss-of-function mutations conferring oxamniquine resistance in a Brazilian schistosome population - PubMed (original) (raw)

Independent origins of loss-of-function mutations conferring oxamniquine resistance in a Brazilian schistosome population

Frédéric D Chevalier et al. Int J Parasitol. 2016 Jun.

Abstract

Molecular surveillance provides a powerful approach to monitoring the resistance status of parasite populations in the field and for understanding resistance evolution. Oxamniquine was used to treat Brazilian schistosomiasis patients (mid-1970s to mid-2000s) and several cases of parasite infections resistant to treatment were recorded. The gene underlying resistance (SmSULT-OR) encodes a sulfotransferase required for intracellular drug activation. Resistance has a recessive basis and occurs when both SmSULT-OR alleles encode for defective proteins. Here we examine SmSULT-OR sequence variation in a natural schistosome population in Brazil ∼40years after the first use of this drug. We sequenced SmSULT-OR from 189 individual miracidia (1-11 per patient) recovered from 49 patients, and tested proteins expressed from putative resistance alleles for their ability to activate oxamniquine. We found nine mutations (four non-synonymous single nucleotide polymorphisms, three non-coding single nucleotide polymorphisms and two indels). Both mutations (p.E142del and p.C35R) identified previously were recovered in this field population. We also found two additional mutations (a splice site variant and 1bp coding insertion) predicted to encode non-functional truncated proteins. Two additional substitutions (p.G206V, p.N215Y) tested had no impact on oxamniquine activation. Three results are of particular interest: (i) we recovered the p.E142del mutation from the field: this same deletion is responsible for resistance in an oxamniquine selected laboratory parasite population; (ii) frequencies of resistance alleles are extremely low (0.27-0.8%), perhaps due to fitness costs associated with carriage of these alleles; (iii) that four independent resistant alleles were found is consistent with the idea that multiple mutations can generate loss-of-function alleles.

Keywords: Biochemical assay; Loss-of-function; Oxamniquine resistance; Schistosoma mansoni; Soft selective event; Sulfotransferase.

Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.

PubMed Disclaimer

Figures

Fig. 1

Fig. 1

Mapping of the mutations on the gene sequence and structure of Schistosoma mansoni SmSUTL-OR sulfotransferase. Exon 1 and exon 2 are represented in orange and beige, respectively. Single nucleotide polymorphisms and insertion/deletion events are represented in cyan and magenta, respectively. Loss-of-function mutations are highlighted in black. (A) Linear representation of the SmSULT-OR gene showing the relative position of the mutations and their translation in amino acid sequences. (B) Positions of mutations on the SmSULT-OR protein. Oxamniquine (OXA) is represented in yellow, 3′-phosphoadenosine-5′-phosphosulfate (PAPS) co-factor is represented in green, and spatial distortions are represented by red discs. For a more detailed view of the mutations on the structure and their functional impact, see Supplementary Move S1.

Fig. 2

Fig. 2

Enzymatic activity of recombinant Schistosoma mansoni SmSULT-OR sulfotransferase expressed from different allelic variants. This in vitro oxamniquine OXA activation assay quantifies DNA-OXA complexes by scintillation (counts per min) (see section 2.9). Bars show the mean of three replicates, while error bars are S.E.M. Enzyme carrying loss-of-function mutations, such as p.C35 or p.E142del, showed no OXA activation, while two newly identified alleles (p.G206V and p.N215Y) did not impair OXA activation. * P < 0.05.

References

    1. Anderson T, Nkhoma S, Ecker A, Fidock D. How can we identify parasite genes that underlie antimalarial drug resistance? Pharmacogenomics. 2011;12:59–85. doi: 10.2217/pgs.10.165. - DOI - PMC - PubMed
    1. Artimo P, Jonnalagedda M, Arnold K, Baratin D, Csardi G, de Castro E, Duvaud S, Flegel V, Fortier A, Gasteiger E, Grosdidier A, Hernandez C, Ioannidis V, Kuznetsov D, Liechti R, Moretti S, Mostaguir K, Redaschi N, Rossier G, Xenarios I, Stockinger H. ExPASy: SIB bioinformatics resource portal. Nucleic Acids Res. 2012;40:W597–W603. doi: 10.1093/nar/gks400. - DOI - PMC - PubMed
    1. Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, Sreng S, Anderson JM, Mao S, Sam B, Sopha C, Chuor CM, Nguon C, Sovannaroth S, Pukrittayakamee S, Jittamala P, Chotivanich K, Chutasmit K, Suchatsoonthorn C, Runcharoen R, Hien TT, Thuy-Nhien NT, Thanh NV, Phu NH, Htut Y, Han KT, Aye KH, Mokuolu OA, Olaosebikan RR, Folaranmi OO, Mayxay M, Khanthavong M, Hongvanthong B, Newton PN, Onyamboko MA, Fanello CI, Tshefu AK, Mishra N, Valecha N, Phyo AP, Nosten F, Yi P, Tripura R, Borrmann S, Bashraheil M, Peshu J, Faiz MA, Ghose A, Hossain MA, Samad R, Rahman MR, Hasan MM, Islam A, Miotto O, Amato R, MacInnis B, Stalker J, Kwiatkowski DP, Bozdech Z, Jeeyapant A, Cheah PY, Sakulthaew T, Chalk J, Intharabut B, Silamut K, Lee SJ, Vihokhern B, Kunasol C, Imwong M, Tarning J, Taylor WJ, Yeung S, Woodrow CJ, Flegg JA, Das D, Smith J, Venkatesan M, Plowe CV, Stepniewska K, Guerin PJ, Dondorp AM, Day NP, White NJ Tracking Resistance to Artemisinin Collaboration (T. R. A. C) Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411–423. - PMC - PubMed
    1. Bhembe NL, Nwodo UU, Govender S, Hayes C, Ndip RN, Okoh AI, Green E. Molecular detection and characterization of resistant genes in Mycobacterium tuberculosis complex from DNA isolated from tuberculosis patients in the Eastern Cape province South Africa. BMC Infect Dis. 2014;14:479. doi: 10.1186/1471-2334-14-479. - DOI - PMC - PubMed
    1. Chang TH, Huang HY, Hsu JBK, Weng SL, Horng JT, Huang HD. An enhanced computational platform for investigating the roles of regulatory RNA and for identifying functional RNA motifs. BMC Bioinformatics. 2013;14(Suppl 2):S4. doi: 10.1186/1471-2105-14-S2-S4. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources